California
Provider Communications
Prior authorization updates for specialty pharmacy
Effective for dates of service on and after July 1, 2021, the following specialty pharmacy codes from current or new Clinical Criteria documents will require prior authorization.
Please note, inclusion of NDC code on your claim will help expedite claim processing of drugs billed with a Not Otherwise Classified (NOC) code.
Visit the Clinical Criteria website to search for the specific Clinical Criteria listed below.
Clinical Criteria |
HCPCS or CPT® Code(s) |
Drug |
ING-CC-0170 |
J1823 |
Uplizna |
ING-CC-0172 |
J3490, J3590, C9071 |
Viltepso |
ING-CC-0173 |
J3490, J3590 |
Enspryng |
ING-CC-0174 |
J3490, J3590, C9399 |
Kesimpta |
ING-CC-0168 |
J9999, C9073 |
Tecartus |
ING-CC-0171 |
J9223 |
Zepzelca |
ING-CC-0169 |
J9316 |
Phesgo |
ING-CC-0175 |
J9015 |
Proleukin |
ING-CC-0176 |
J9032 |
Beleodaq |
ING-CC-0178 |
J9262 |
Synribo |
ING-CC-0177 |
J3304 |
Zilretta |
ING-CC-0002 |
Q5122 |
Nyvepria |
ING-CC-0038 |
J3110 |
Forteo |
ING-CC-0179 |
J9999, C9069 |
Blenrep |
ING-CC-0180 |
J3490, J3590, J9999, C9070 |
Monjuvi |
ING-CC-0181 |
J3490 |
Veklury |
If you have questions about this communication or need further assistance, please contact your local Provider Relations representative.
ACA-NU-0330-21
Featured In:
June 2021 Anthem Blue Cross Provider News - California